| 1. |
- Lara-Cerón, Jesús A., et al.
(författare)
-
Ultrasound-assisted synthesis of organotin compounds and their application as luminescent dye in silk fibroin scaffolds
- 2020
-
Ingår i: Inorganica Chimica Acta. - : Elsevier BV. - 0020-1693. ; 505
-
Tidskriftsartikel (refereegranskat)abstract
- In this work, we report the green synthesis of four luminescent organotin compounds 1–4 derived from amino acid Schiff bases (1: Naph-Trp-SnPh2, 2: Naph-Tyr-SnBu2, 3: Naph-Tyr-SnPh2, 4: Naph-Phe-SnPh2), obtained by ultrasound-assisted synthesis in short time (~20 min) and good yields (>95%). The molecular structure proposed in solution (1H and 119Sn NMR) was confirmed by X-ray diffraction study for compound 1 where the tin atom resides in trigonal bipyramid geometry. Luminescent silk fibroin scaffolds (SF 1–4) were elaborated with organotin compounds by freeze-drying technique. Photophysical properties of organotin compounds and scaffolds were obtained in solid state, observing bathochromic behaviors in tyrosine derived compounds, suggesting that the tyrosine produce supramolecular interactions across the –OH group that change the fluorescent properties. Scaffolds 1–4 were characterized by FTIR, XDR, TG/DTG, and SEM analysis. In addition, cytotoxic analysis of SF 1 presents high cellular viability, which could be applied as a scaffold in tissue engineering.
|
|
| 2. |
- Sábio, Rafael M., et al.
(författare)
-
Near-Infrared Luminescence from Visible-Light-Sensitized Ruthenium(II)-Neodymium(III) Heterobimetallic Bridged Complexes Containing Alkoxy(silyl) Functional Groups
- 2020
-
Ingår i: Journal of the Brazilian Chemical Society. - : Sociedade Brasileira de Quimica (SBQ). - 0103-5053 .- 1678-4790. ; 31:4, s. 694-702
-
Tidskriftsartikel (refereegranskat)abstract
- New infrared emitting d-f (ruthenium(II)–neodymium(III)) heterobimetallic complexes with alkoxy(silyl) functional groups have been prepared. Visible excitation evidenced energy transfer processes from the ruthenium(II) donor to neodymium(III) acceptors leading to infrared emission. Energy transfer rates (kEnT) and efficiency of energy transfer (ηEnT) are, respectively, 0.61 × 107 s-1 and 44% for RuL1–NdL3 complex. Larger values of kEnT (3.04 × 107 s-1) and ηEnT (84%) were detected for RuL2–NdL4 complex. RuL1–NdL3 and RuL2–NdL4 complexes were fully characterized by elementary analysis (EA), mass spectrometry (MS), Fourier transform infrared spectroscopy (FTIR) and Fourier transform Raman spectroscopy (FT-Raman). Total correlation spectroscopy (TOCSY1D), 1H{13C} heteronuclear single quantum correlation (HSQC) and 1H{13C} heteronuclear multiple bond correlation (HMBC) nuclear magnetic resonance (NMR) analyses were also carried out to characterize NdL3 and RuL1–NdL3 complexes. The presence of trialkoxysilyl-substituted ligands would allow further grafting onto any silica or silicated surface aiming at applications as new luminescent near infrared (NIR)-emitting biosensors or biomarkers.
|
|
| 3. |
- Ferreira, Vitor, et al.
(författare)
-
Modulation of hypothalamic AMPK phosphorylation by olanzapine controls energy balance and body weight
- 2022
-
Ingår i: Metabolism. - : Elsevier. - 0026-0495 .- 1532-8600. ; 137
-
Tidskriftsartikel (refereegranskat)abstract
- Background: Second-generation antipsychotics (SGAs) are a mainstay therapy for schizophrenia. SGA-treated patients present higher risk for weight gain, dyslipidemia and hyperglycemia. Herein, we evaluated the effects of olanzapine (OLA), widely prescribed SGA, in mice focusing on changes in body weight and energy balance. We further explored OLA effects in protein tyrosine phosphatase-1B deficient (PTP1B-KO) mice, a preclinical model of leptin hypersensitivity protected against obesity. Methods: Wild-type (WT) and PTP1B-KO mice were fed an OLA-supplemented diet (5 mg/kg/day, 7 months) or treated with OLA via intraperitoneal (i.p.) injection or by oral gavage (10 mg/kg/day, 8 weeks). Readouts of the crosstalk between hypothalamus and brown or subcutaneous white adipose tissue (BAT and iWAT, respectively) were assessed. The effects of intrahypothalamic administration of OLA with adenoviruses expressing constitutive active AMPK alpha 1 in mice were also analyzed. Results: Both WT and PTP1B-KO mice receiving OLA-supplemented diet presented hyperphagia, but weight gain was enhanced only in WT mice. Unexpectedly, all mice receiving OLA via i.p. lost weight without changes in food intake, but with increased energy expenditure (EE). In these mice, reduced hypothalamic AMPK phosphorylation concurred with elevations in UCP-1 and temperature in BAT. These effects were also found by intrahypothalamic OLA injection and were abolished by constitutive activation of AMPK in the hypothalamus. Additionally, OLA i. p. treatment was associated with enhanced Tyrosine Hydroxylase (TH)-positive innervation and less sympathetic neuron-associated macrophages in iWAT. Both central and i.p. OLA injections increased UCP-1 and TH in iWAT, an effect also prevented by hypothalamic AMPK activation. By contrast, in mice fed an OLA-supplemented diet, BAT thermogenesis was only enhanced in those lacking PTP1B. Our results shed light for the first time that a threshold of OLA levels reaching the hypothalamus is required to activate the hypothalamus BAT/iWAT axis and, therefore, avoid weight gain. Conclusion: Our results have unraveled an unexpected metabolic rewiring controlled by hypothalamic AMPK that avoids weight gain in male mice treated i.p. with OLA by activating BAT thermogenesis and iWAT browning and a potential benefit of PTP1B inhibition against OLA-induced weight gain upon oral treatment.
|
|
